EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Diagnosis and Management of Early Stages of ALD

Jordi Gratacós-Ginès, Edilmar Alvarado-Tapias, David Martí-Aguado, Hugo López-Pelayo, Ramón Bataller, Elisa Pose

Seminars in Liver Disease · 01.06.2025 · 45 (02) · 195-209

DOI: 10.1055/a-2541-2892 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.06.2025. Verfasst von Jordi Gratacós-Ginès und 5 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit, Hospital Clínic de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 163 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early forms of alcohol-associated liver disease (ALD) include different stages in the progression of compensated liver disease ranging from steatosis to steatohepatitis and fibrosis. ALD has been classically diagnosed at advanced stages more frequently than other liver diseases. This fact probably contributed to the scarcity of studies on early forms of ALD. Recent studies have investigated the prevalence of early ALD in the general population and have described the natural history of alcohol-induced steatosis and fibrosis, which have been linked to worse prognosis compared with early stages of other chronic liver diseases. In addition, studies on screening and early diagnosis of ALD in at-risk populations have shown that these strategies allow early detection and intervention. Of note, up to 28% of the United States population has concurrent alcohol use and metabolic syndrome, and estimated prevalence of advanced fibrosis among heavy drinkers with metabolic syndrome has increased from 3% in the 1990s to more than 10% in the 2010s. Therefore, new challenges and treatment opportunities will emerge for patients with ALD. In this review, we provide an overview of the state of the art in early ALD, focusing on natural history, diagnosis, and management, and provide insights into future perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Diseases, AlcoholicHumansEarly DiagnosisDisease ProgressionRisk FactorsPrognosisPredictive Value of TestsPrevalenceMetabolic Syndrome

Autor:innen und Institutionen

  • Liver Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
  • Department of Gastroenterology and Hepatology, Hospital of Santa Creu and Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
  • Digestive Disease Department, Clínic University Hospital, Biomedical Research Institute INCLIVA, Valencia, Spain.
  • Addictions Unit, Psychiatry and Psychology Service, ICN, Hospital Clínic de Barcelona, Barcelona, Spain.

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Gratacós-Ginès, J., Alvarado-Tapias, E., Martí-Aguado, D., López-Pelayo, H., Bataller, R., & Pose, E. (2025). Diagnosis and Management of Early Stages of ALD. Seminars in Liver Disease, 45(02), 195-209. https://doi.org/10.1055/a-2541-2892

Vancouver

Gratacós-Ginès J, Alvarado-Tapias E, Martí-Aguado D, López-Pelayo H, Bataller R, Pose E. Diagnosis and Management of Early Stages of ALD. Seminars in Liver Disease. 2025;45(02):195-209. doi:10.1055/a-2541-2892

BibTeX
@article{GratacsGins2025,
  author = {Gratacós-Ginès, Jordi and Alvarado-Tapias, Edilmar and Martí-Aguado, David and López-Pelayo, Hugo and Bataller, Ramón and Pose, Elisa},
  title = {Diagnosis and Management of Early Stages of ALD},
  journal = {Seminars in Liver Disease},
  year = {2025},
  volume = {45},
  number = {02},
  pages = {195--209},
  doi = {10.1055/a-2541-2892}
}
Kostenlos starten →